- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06497816
Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD
July 4, 2024 updated by: Aslihan Cakmak, Hacettepe University
An Investigation of Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in Chronic Obstructive Pulmonary Disease and Healthy Individuals
Health literacy is important for controlling disease progression and living a healthy life with illness.
High health literacy is associated with higher cognitive performance and lower health-related quality of life.
Physical, psychological, and social impairments are seen in chronic obstructive pulmonary disease (COPD).
Studies investigating the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD are limited.
Therefore, the aim of this study was to compare individuals with COPD with healthy individuals in terms of health literacy, functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living and to investigate the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
144
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aslihan Cakmak-Onal, PhD, PT
- Phone Number: 178 03123051576
- Email: aslihancakmak90@gmail.com
Study Contact Backup
- Name: Elif Kocaaga, MSc, PT
- Email: elifkocaaga86@gmail.com
Study Locations
-
-
-
Ankara, Turkey, 06100
- Recruiting
- Hacettepe University Faculty of Physical Therapy and Rehabilitation
-
Contact:
- Aslihan Cakmak-Onal, PhD, PT
- Phone Number: 178 03123051576
- Email: aslihancakmak90@gmail.com
-
Principal Investigator:
- Aslihan Cakmak-Onal, PhD, PT
-
Sub-Investigator:
- Elif Kocaaga, MSc, PT
-
Sub-Investigator:
- Deniz Inal-Ince, PhD, PT
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Individuals with COPD and Healthy Controls
Description
Inclusion criteria for the COPD group:
- Being over 40 years old,
- Diagnosed with COPD and being clinically stable,
- Being able to cooperate with the tests to be performed,
- Not having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
- Being willing to participate in the study.
Exclusion criteria for the COPD group:
- Being in an acute exacerbation period,
- Having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
- Not being willing to participate in the study.
Inclusion criteria for the control group:
- Being willing to participate in the study and being over 40 years old
- Not having any known disease
Exclusion criteria for the control group:
- Not being able to cooperate with the tests to be performed
- Not being willing to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
COPD
Individuals with stable COPD
|
No intervention
|
|
Healthy Individuals
Healthy controls
|
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional capacity
Time Frame: 1st day
|
Functional capacity assessment using self-paced 6-minute walk test.
|
1st day
|
|
Health literacy
Time Frame: 1st day
|
Test of Functional Health Literacy in Adults will be used to evaluate health literacy.
The TOFHLA is scored on a scale of 0 to 100 and higher scores indicate higher health literacy.
|
1st day
|
|
Health literacy
Time Frame: 1st day
|
The Rapid Estimate of Adult Literacy in Medicine questionnaires will be performed.
A score of 59 or less is defined as indicating low health literacy and a score of 60 or more indicates adequate health literacy.
|
1st day
|
|
Cognitive function
Time Frame: 1st day
|
Montreal Cognitive Assessment will be used to evaluate cognitive function.
The Montreal Cognitive Assessment scores range between 0 and 30.
A score of 26 or over is considered to be normal.
|
1st day
|
|
Health-related behavior
Time Frame: 1st day
|
Health-related Behavior Scale II will be performed to assess health-related behavior.
The Health-related Behavior Scale II measures various health-related behaviors and is designed to assess the frequency or extent of engagement in these behaviors.
Higher scores of the scale indicate more frequent or healthier behaviors, depending on the specific behavior being measured.
|
1st day
|
|
Functional exercise capacity
Time Frame: 1st day
|
One-minute sit to stand test will be performed.
The number of repetitions will be recorded.
|
1st day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Forced vital capacity
Time Frame: 1st day
|
Pulmonary function test using a spirometer will be performed.
Forced vital capacity will be recorded.
|
1st day
|
|
Forced expiratory volume in one second
Time Frame: 1st day
|
Pulmonary function test using a spirometer will be performed.
Forced expiratory volume in one second will be recorded.
|
1st day
|
|
forced expiratory volume in one second/forced vital capacity ratio
Time Frame: 1st day
|
Pulmonary function test using a spirometer will be performed.
Forced expiratory volume in one second/forced vital capacity ratio will be recorded.
|
1st day
|
|
Peak expiratory flow
Time Frame: 1st day
|
Pulmonary function test using a spirometer will be performed.
Peak expiratory flow will be recorded.
|
1st day
|
|
Forced mid-expiratory flow (FEF25-75)
Time Frame: 1st day
|
Pulmonary function test using a spirometer will be performed.
Forced mid-expiratory flow (FEF25-75) will be recorded.
|
1st day
|
|
Physical activity level
Time Frame: 1st day
|
Physical activity will be evaluated with International Physical Activity Questionnaire questionnaire.
The questionnaire assesses physical activity across different domains, including leisure time, domestic and gardening activities, work-related activities, and transport-related activities.
Scores are calculated based on the duration (minutes) and frequency (days) of these activities over the past seven days.
Higher scores on the IPAQ indicate a higher level of physical activity.
|
1st day
|
|
Assessment of quality of life
Time Frame: 1st day
|
St. George quality of life questionnaire will be used to assess quality of life.
Higher scores reflect worse health status.
|
1st day
|
|
Activities of daily living
Time Frame: 1st day
|
Activities of daily living will be evaluated using Leicester Cough Questionnaire.
Each question is scored on a scale from 1 (maximum impact) to 7 (minimal impact).
An average score is calculated for each domain (physical, psychological, and social), resulting in scores ranging from 1 to 7 per domain, and a total score between 3 and 21.
A higher score indicates less impact.
|
1st day
|
|
Assessment of quality of life
Time Frame: 1st day
|
Short Form-36 will be applied for assessing quality of life.
Higher scores indicate better health status.
|
1st day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Aslihan Cakmak-Onal, PhD, PT, Hacettepe University
- Study Director: Deniz Inal-Ince, PhD, PT, Hacettepe University
- Principal Investigator: Elif Kocaaga, MSc, PT, Hacettepe University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2024
Primary Completion (Estimated)
June 15, 2027
Study Completion (Estimated)
June 15, 2027
Study Registration Dates
First Submitted
June 28, 2024
First Submitted That Met QC Criteria
July 4, 2024
First Posted (Actual)
July 12, 2024
Study Record Updates
Last Update Posted (Actual)
July 12, 2024
Last Update Submitted That Met QC Criteria
July 4, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- SBA24/414
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown